Gecko Biomedical, a Paris, France-based medical device company developing ‘bio-inspired’ biodegradable surgical glues and patches for wound closure, raised €1.3m in funding.
Bpifrance made the investment.
The company intends to use the funds to advance the manufacturing scale-up of its Liquid Film platform, and the completion of the non-clinical development plan for regulatory purposes.
Led by Christophe Bancel, Chief Executive Officer, Gecko Biomedical is dedicated to the development and the commercialization of biodegradable sealants and adhesives for wound closure in the field of surgery, with a focus on minimally invasive surgery.
Founded in 2013, the company is backed by healthcare investors Omnes Capital, CM-CIC and CapDecisif Management.